CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | COZADD BRUCE C Director | Option exercise | +734 | $136.18 | $100K | 340,609 |
| 2026-11-06 | COZADD BRUCE C Director | Option exercise | +85,766 | $136.18 | $11.7M | 426,375 |
| 2026-11-06 | COZADD BRUCE C Director | Sale | −27,714 | $234.91 | $6.5M | 398,661 |
| 2026-11-06 | COZADD BRUCE C Director | Sale | −10,688 | $235.82 | $2.5M | 387,973 |
| 2026-11-06 | COZADD BRUCE C Director | Sale | −24,483 | $236.84 | $5.8M | 363,490 |
| 2026-11-06 | COZADD BRUCE C Director | Sale | −5,923 | $237.39 | $1.4M | 357,567 |
| 2026-11-06 | COZADD BRUCE C Director | Option exercise · Incentive Stock Option (right to buy) | −734 | 0 | ||
| 2026-11-06 | COZADD BRUCE C Director | Option exercise · Non-Qualified Stock Option (right to buy) | −85,766 | 0 | ||
| 2026-11-04 | Carr Patricia SVP, Chief Accounting Officer | Option exercise | +1,250 | $140.03 | $175K | 7,925 |
| 2026-11-04 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,250 | $231.37 | $289K | 6,675 |
| 2026-11-04 | Carr Patricia SVP, Chief Accounting Officer | Sale | −163 | $231.27 | $38K | 6,512 |
| 2026-11-04 | Carr Patricia SVP, Chief Accounting Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −1,250 | 3,000 | ||
| 2026-11-03 | GALA RENEE D President & CEO | Sale 10b5-1 | −1,000 | $225.37 | $225K | 140,394 |
| 2026-11-02 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $215.84 | $1.3M | 339,875 |
| 2026-10-06 | GALA RENEE D President & CEO | Sale 10b5-1 | −2,000 | $236.40 | $473K | 141,394 |
| 2026-10-01 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $230.33 | $1.4M | 345,875 |
| 2026-09-10 | Patil Neena M EVP & Chief Legal Officer | Sale 10b5-1 | −1,200 | $240.94 | $289K | 47,671 |
| 2026-09-08 | Henderson Mary Elizabeth SVP, Technical Operations | Shares withheld for taxes | −1,412 | $243.03 | $343K | 23,830 |
| 2026-09-08 | Henderson Mary Elizabeth SVP, Technical Operations | Shares withheld for taxes | −15 | $241.20 | $4K | 23,815 |
| 2026-09-08 | GALA RENEE D President & CEO | Shares withheld for taxes 10b5-1 | −1,967 | $246.81 | $485K | 145,394 |
Page 1 of 19 · 365 trades